SEC Form D · Amendment · filed November 1, 2017
M3 Biotechnology, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (15)
Joseph W. Harding · Seattle, WADirectorJohn Fluke · Seattle, WAExec · DirectorBruce Montgomery · Seattle, WADirectorMichael M. Montgomery · Seattle, WADirectorLeen Kawas · Seattle, WAExec · DirectorNiraj F. Mehta · Oakland, CADirectorConifer Management, L.L.C · New York, NYDirector[Entity] Lasalle Income & Growth Fund Viii GP, L.L.C · CHICAGO, ILDirectorTimothy M. Miller · Bellefonte, PAExec · DirectorGregory Alexander · New York, NYExec · DirectorMarc A. Schneebaum · Madison, WIExec · DirectorAndrew E. Ferrara · Madison, WIDirectorJames H. Schmidt · Evans City, PAExec · DirectorTimothy F. Keaney · Oakland, CADirectorGlobal Pacific Funding, LLC · Phoenix, AZDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗